Remifentanil is a potent intravenous short-acting synthetic opioid. It acts as a µ-receptor agonist. Remifentanil is rapidly hydrolyzed by plasma and tissue esterases. It is unique in that it displays no context-sensitivity. In other words, it does not accumulate with prolonged infusion. The context-sensitive half-life is ~4 minutes. It is useful for procedures requiring profound […]